Bacteria and other microorganisms that have developed resistance to most antibiotics are largely known in the world as superbugs, but they can be a vague concept that the majority of people don’t care about. The UN doesn’t share the same opinion, however, as the international organization has just elevated the threat to a Crisis Level health issue. This is only the fourth time that the body of nations decided to do this, which is indicative of how seriously countries should take superbugs.
Modern antibiotics have been around for over 70 years, but the concept of using substances to combat bacterial infections have been around for far longer, Futurism reports. However, due to the long exposure to the drugs as well as the mass dumping of antibiotics in sewers, garbage sites, and even the ocean, resistant strains have started appearing.
These drug-resistant superbugs are not just a threat to humans either since there are also similarly toughened microorganisms that can infect crops, animals, and even farmed fish. As a result, Ban Ki-moon, the secretary general at the UN declared superbugs as “fundamental, long-term threat to human health, sustainable food production and development.”
In a recent gathering of UN officials, the secretary general detailed how superbugs currently threaten humanity as a whole. He also stressed that this is not a threat that’s far off into the future. It is happening right now.
“More than 200,000 newborn children are estimated to die each year from infections that do not respond to available antibiotics. An epidemic of multidrug-resistant typhoid is now sweeping across parts of Africa, being spread through water. Resistance to HIV/AIDS drugs is on the rise. Extensively drug-resistant tuberculosis has been identified in 105 countries. And resistance to antimalarial medicines is an urgent public health concern in the Greater Mekong sub-region,” Mr. Ban Ki-moon said.


RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
The four types of dementia most people don’t know exist
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 



